Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 824

1.

Saul Genuth, MD: Clinical Researcher and Leader in Developing Modern Diabetes Treatment.

Jacobson AM, Nathan DM.

Diabetes Care. 2015 Mar;38(3):347-51. doi: 10.2337/dc14-1396. No abstract available.

PMID:
25715411
[PubMed - in process]
2.

Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD study.

Pownall HJ, Bray GA, Wagenknecht LE, Walkup MP, Heshka S, Hubbard VS, Hill J, Kahn SE, Nathan DM, Schwartz AV, Johnson KC; Look AHEAD Research Group.

Obesity (Silver Spring). 2015 Mar;23(3):565-72. doi: 10.1002/oby.21005.

PMID:
25707379
[PubMed - in process]
3.

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.

Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, Lachin JM.

JAMA. 2015 Jan 6;313(1):45-53. doi: 10.1001/jama.2014.16107.

PMID:
25562265
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Advances in sickle cell therapies in the hydroxyurea era.

Field JJ, Nathan DG.

Mol Med. 2014 Dec 16;20 Suppl 1:S37-42. doi: 10.2119/molmed.2014.00187.

PMID:
25549232
[PubMed - in process]
Free Article
5.

A conversation with David Nathan.

Nathan D, Neill US.

J Clin Invest. 2014 Dec;124(12):5090-1. doi: 10.1172/JCI78143. Epub 2014 Dec 1. No abstract available.

PMID:
25438058
[PubMed - in process]
6.

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE.

Cancer. 2015 Jan 15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15.

PMID:
25223899
[PubMed - in process]
7.

Exploring Variations in Functional Connectivity of the Resting State Default Mode Network in Mild Traumatic Brain Injury.

Nathan DE, Oakes TR, Yeh PH, French LM, Harper JF, Liu W, Wolfowitz RD, Wang BQ, Graner JL, Riedy G.

Brain Connect. 2014 Sep 15. [Epub ahead of print]

PMID:
25222050
[PubMed - as supplied by publisher]
8.

Effect of phosphodiesterase inhibition on insulin resistance in obese individuals.

Ho JE, Arora P, Walford GA, Ghorbani A, Guanaga DP, Dhakal BP, Nathan DI, Buys ES, Florez JC, Newton-Cheh C, Lewis GD, Wang TJ.

J Am Heart Assoc. 2014 Sep 11;3(5):e001001. doi: 10.1161/JAHA.114.001001.

PMID:
25213566
[PubMed - in process]
Free PMC Article
9.

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor.

Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, Yang JC, Phan GQ, Hughes MS, Sherry RM, Raffeld M, Feldman S, Lu L, Li YF, Ngo LT, Goy A, Feldman T, Spaner DE, Wang ML, Chen CC, Kranick SM, Nath A, Nathan DA, Morton KE, Toomey MA, Rosenberg SA.

J Clin Oncol. 2015 Feb 20;33(6):540-9. doi: 10.1200/JCO.2014.56.2025. Epub 2014 Aug 25.

PMID:
25154820
[PubMed - in process]
10.

Glycemic control after hospital discharge in insulin-treated type 2 diabetes: a randomized pilot study of daily remote glucose monitoring.

Wei NJ, Nathan DM, Wexler DJ.

Endocr Pract. 2015 Feb 1;21(2):115-21. doi: 10.4158/EP14134.OR.

PMID:
25148814
[PubMed - in process]
11.

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Sep;37(9):2548-56. doi: 10.2337/dc14-0093.

PMID:
25147253
[PubMed - in process]
12.

Hereditary xerocytosis revisited.

Archer NM, Shmukler BE, Andolfo I, Vandorpe DH, Gnanasambandam R, Higgins JM, Rivera A, Fleming MD, Sachs F, Gottlieb PA, Iolascon A, Brugnara C, Alper SL, Nathan DG.

Am J Hematol. 2014 Dec;89(12):1142-6. doi: 10.1002/ajh.23799. Epub 2014 Jul 21. No abstract available.

PMID:
25044010
[PubMed - indexed for MEDLINE]
13.

Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Rutter MK, Sullivan LM, Fox CS, Wilson PW, Nathan DM, Vasan RS, D'Agostino RB Sr, Meigs JB.

Metab Syndr Relat Disord. 2014 Sep;12(7):372-80. doi: 10.1089/met.2013.0148. Epub 2014 Jul 9.

PMID:
25007010
[PubMed - in process]
14.

How best to teach developmental assessment? A single-blinded randomised study.

Feyereislova S, Nathan D.

Arch Dis Child. 2014 Dec;99(12):1083-6. doi: 10.1136/archdischild-2013-305536. Epub 2014 Jun 23.

PMID:
24958795
[PubMed - indexed for MEDLINE]
15.

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Goergen LG, Balliro C, Hillard MA, Nathan DM, Damiano ER.

N Engl J Med. 2014 Jul 24;371(4):313-25. doi: 10.1056/NEJMoa1314474. Epub 2014 Jun 15.

PMID:
24931572
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Connecting combat-related mild traumatic brain injury with posttraumatic stress disorder symptoms through brain imaging.

Costanzo ME, Chou YY, Leaman S, Pham DL, Keyser D, Nathan DE, Coughlin M, Rapp P, Roy MJ.

Neurosci Lett. 2014 Aug 8;577:11-5. doi: 10.1016/j.neulet.2014.05.054. Epub 2014 Jun 4.

PMID:
24907686
[PubMed - in process]
17.

A comparative effectiveness analysis of three continuous glucose monitors: the navigator, g4 platinum, and enlite.

Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ.

J Diabetes Sci Technol. 2014 Jul;8(4):699-708. doi: 10.1177/1932296814532203. Epub 2014 Apr 21.

PMID:
24876423
[PubMed - in process]
18.

Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.

Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, Coday M, Crow SJ, Curtis JM, Dutton G, Egan C, Evans M, Ewing L, Faulconbridge L, Foreyt J, Gaussoin SA, Gregg EW, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Knowler WC, Lang W, Lewis CE, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Rejeski WJ, Rosenthal RH, Ruelas V, Toledo K, Van Dorsten B, Vitolins M, Williamson D, Wing RR, Yanovski SZ, Zhang P; Look AHEAD Research Group.

Diabetes Care. 2014 Jun;37(6):1544-53. doi: 10.2337/dc13-1928.

PMID:
24855155
[PubMed - indexed for MEDLINE]
19.

Musculoskeletal complications in type 1 diabetes.

Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, Gatcomb P, Golden E, Lipps J, Lorenzi G, Mahony C, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2014 Jul;37(7):1863-9. doi: 10.2337/dc13-2361. Epub 2014 Apr 10.

PMID:
24722493
[PubMed - indexed for MEDLINE]
20.

Understanding the importance of natural neuromotor strategy in upper extremity neuroprosthetic control.

Nathan DE, Prost RW, Guastello SJ, Jeutter DC.

Int J Bioinform Res Appl. 2014;10(2):217-34. doi: 10.1504/IJBRA.2014.059521.

PMID:
24589839
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk